Tel: +44 (0) 1904 406082

“Creating better health outcomes for animals, humans and plants”

Abingdon Health is an industry leader in the development and high-volume manufacture of lateral flow immunoassay rapid diagnostic products and reader systems. Offering an unrivaled suite of services, from development through to commercialisation, to a global customer base from a variety of regulated and non-regulated industry sectors.

Abingdon Health is certified to ISO 9001:2015 and ISO 13485:2016 and is GMP (Good Manufacturing Practice) compliant with the U.S. Food and Drug Administration (FDA).

The foundation of everything we do

We support our customers’ product and organisational ambitions by offering a flexible and value for money service that consistently produces rapid diagnostic devices that meet safety, quality and reliability expectations and requirements.

At Abingdon Health we strongly believe that achieving excellence in employee training and development, meeting stakeholder needs and expectations and building robust long-term partnerships with customers and suppliers ensures the production of quality rapid diagnostic products.

For generations to come, Abingdon Health will continue to innovate and be a knowledge leader in our field to allow the world to experience the many health and economic benefits offered by lateral flow rapid diagnostics.

Our promise to you

Having produced our own lateral flow products and products for our partners over many years, we understand our customers and their requirements during the development and manufacture process. Each project we undertake follows a robust new product development and design review process that draws on this experience in-line with our ISO certification. A defined and methodical path is created to provide a transparent and collaborative approach with the customer.

Our strategic objectives are:

  • To provide best-in-class lateral flow assays and high quality manufacturing service to our customers.
  • To develop and commercialise rapid diagnostics products that will aim to improve the health outcomes of animals, humans and plants.
  • To innovate our assay and reader technology to provide state-of-the-art technology that supports customer, market and end-user needs.

Learn more about Abingdon Health’s end-to-end services




Abingdon Health is a member of Medilink